Research Radartracking 2 published studies · 1 clinical trials · 2 cancer pages · updated Jun 2026Open the Research Map →

Chlorella Powder

Algae powder that binds carcinogens, boosts NK/Th1 immunity, upregulates antioxidants; preclinical apoptosis signals with human supportive data.

← All agents

Human-reviewed · How we review →

AI extractedhuman reviewedsources checkedretractions suppressed

👥⭐⭐⭐ Moderate — Human trials show immune/antioxidant effects and reduced carcinogen exposure; anti-tumor actions mostly preclinical with limited patient data.Chlorella vulgaris powderGreen algae supplement

Forms: Chlorella powder (loose or capsules, 3–10 g per serving)

Educational only, not medical advice. OncoForge makes no claim that Chlorella Powder treats, prevents, or cures any condition, beyond what the linked studies show. Evidence levels vary; effects may not translate to people, and some compounds can cause harm. Always coordinate with your oncology team.

Simple Summary

Chlorella helps block/clear some food-borne carcinogens, boosts NK-cell activity in human trials, and can trigger tumor-cell apoptosis in lab work. It’s best viewed as preventive/supportive—pairing with therapy and diet cleanup—rather than a stand-alone anticancer treatment.

Evidence at a glance

Tier 3 · early humanBreast (QoL pilot)Colon (apoptosis models)Various (preclinical)

Human RCTs for immune/detox; preclinical for direct anti-tumor; limited oncology outcomes.

How it may work

Chlorella’s chlorophyllin binds dietary carcinogens (e.g., aflatoxin, heterocyclic amines), reducing their bioavailability. Supplementation can increase NK cell activity and Th1 cytokines (IFN-γ, IL-12) in humans, upregulate antioxidant enzymes (SOD, catalase), and in cancer cell models trigger apoptosis via p53/Bax/caspase-3 with decreased Bcl-2.

Targets & pathways

Curated mechanistic targets reported for this agent — how it may act on cells, not proof of a clinical effect.

  • Carcinogen Binding / Detox↑Chlorophyllin reduces bioavailability of toxins
  • NK Cell Activity↑
  • Th1 Cytokines (IFN-γ, IL-12)↑
  • Antioxidant Enzymes (SOD, Catalase)↑
  • Apoptosis↑p53/Bax/caspase-3 ↑; Bcl-2 ↓
DetoxNK ↑Apoptosis ↑

Often studied / combined with

Combinations reported in the literature, not a protocol or a recommendation.

Overlapping mechanisms

Safety & interactions

Severity and how well-established each signal is are shown separately. Verify everything with your oncologist or pharmacist — absence here does not mean safe.

Risk categories
Gi Upset MildAllergic ReactionsAnticoagulant CautionImmune Stimulation Risk
Potential interactions
  • Warfarin / AnticoagulantsMonitorModerateTheoreticalVitamin K antagonism → INR changes.
  • ImmunosuppressantsAvoidMajorTheoreticalMay counteract effects.
  • ChemotherapyConsiderBeneficialTheoreticalPotential QoL/immune support; preclinical synergies.

Timing

References

Research

No published studies for Chlorella Powder yet

New studies appear here once they’ve been reviewed. Browse all studies.

Dose: as studied, not a recommendation

These are doses as studied or reported, never a recommendation. The right amount of Chlorella Powder depends on you, your other medicines, and your situation; decide it with your oncology team and pharmacist, not from a web page.

Ranges seen in adjunct / practice use: 3–10 g (po) Once or divided daily. Based on human RCTs: 6–10 g/day for immune/antioxidant effects; start low for tolerance in oncology adjunct., No Rx required. Take with water/meals; oncology supportive—consult clinician. Build tolerance to avoid GI upset..

Trials studying Chlorella Powder

No actively-recruiting trials matched right now. Recruiting is not the same as proven. Search ClinicalTrials.gov →

Inclusion here is not an endorsement. OncoForge makes no claim beyond what the linked studies show. Discuss anything on this page with your oncology team before acting on it.

← All agents · Research Radar